Key facts
- This page summarizes Ram R. Krishnan's Form 4 filing for EMERSON ELECTRIC CO (EMR).
- 6 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 14 Nov 2025, 16:32.
Ram R. Krishnan - 12 Nov 2025 Form 4 Insider Report for EMERSON ELECTRIC CO (EMR)
- Reporting relationship
- Executive Vice Pres & COO
- Issuer ticker
- EMR
- Reported as of
- 12 Nov 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Nov 2025, 16:32:05 UTC
- Prior SEC filing
- 10 Nov 2025
- Next SEC filing
- 12 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John A. Sperino, Attorney-in-Fact for Ram R. Krishnan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ram R. Krishnan filed Form 4 for EMERSON ELECTRIC CO (EMR) on 14 Nov 2025.
Change
- Previous filing in this sequence was filed on 10 Nov 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001847946
Primary reporting owner
Krishnan Ram R.
- Relationship
- Executive Vice Pres & COO
- Address
- C/O EMERSON ELECTRIC CO., 8027 FORSYTH BLVD., ST. LOUIS
- Signature
- /s/ John A. Sperino, Attorney-in-Fact for Ram R. Krishnan
- Signature date
- 14 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EMR
transaction
Common Stock
Gift
- Transaction value
- Shares
- -77
- Change %
- -0.06%
- Price
- Shares after
- 124,967
- Date
- 12 Nov 2025
- Ownership
- By Trust
- Footnotes
- F1, F2
EMR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 104,857
- Date
- 12 Nov 2025
- Ownership
- Direct
EMR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,047
- Date
- 12 Nov 2025
- Ownership
- 401(k) plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EMR
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +70,000
- Change %
- Price
- Shares after
- 70,000
- Date
- 13 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $128.46
- Footnotes
- F3, F4, F5
EMR
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +70,000
- Change %
- Price
- Shares after
- 70,000
- Date
- 13 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $160.58
- Footnotes
- F3, F4, F5, F6
EMR
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +70,000
- Change %
- Price
- Shares after
- 70,000
- Date
- 13 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $192.69
- Footnotes
- F3, F4, F5, F7
EMR
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +70,000
- Change %
- Price
- Shares after
- 70,000
- Date
- 13 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $224.80
- Footnotes
- F3, F4, F5, F8
EMR
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +70,000
- Change %
- Price
- Shares after
- 70,000
- Date
- 13 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $256.92
- Footnotes
- F3, F4, F5, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Bona Fide gift by Reporting Person of 77 shares to United Way.
Footnote F2
Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.
Footnote F3
Grant of stock options under shareholder approved benefit plan exempt pursuant to Rule 16b-3(d).
Footnote F4
The Reporting person was awarded a total of 350,000 stock options on 11/13/2025 in 5 tranches of 70,000 stock options each, with each tranche having a different exercise price. Each of the 5 tranches of 70,000 stock options become exercisable in five equal annual installments of 14,000 each beginning on 11/13/2026.
Footnote F5
Price is not applicable to stock options received as incentive compensation.
Footnote F6
The exercise price is equal to 125% of the closing price of Issuer's common stock on the date of grant.
Footnote F7
The exercise price is equal to 150% of the closing price of Issuer's common stock on the date of grant.
Footnote F8
The exercise price is equal to 175% of the closing price of Issuer's common stock on the date of grant.
Footnote F9
The exercise price is equal to 200% of the closing price of Issuer's common stock on the date of grant.